Dog /

Breed profile · FDA CVM July 2026 extract

Elkhound - Norwegian Grey adverse-event record

Adverse-event filings for Elkhound - Norwegian Grey (Dog) in the FDA Center for Veterinary Medicine openFDA extract. Browse dog breeds, reactions, and outcomes below.

Verify with FDA CVM →
#237 of 510
by report volume (all breeds)
93
FDA CVM reports on file
3.2%
death-coded share of reports
#219 of 275
by death-coded share (≥50 reports)

How the 93 reports break down

By recorded gender -- every report on file for Elkhound - Norwegian Grey, no filtering.

Annual report volume

Annual adverse-event report trend Yearly FDA CVM adverse-event report counts for this breed. 16 12 8 4 0 2019 2020 2021 2022 2023 2024 2025 2026 Reports filed Death-coded reports
Annual report volume for Elkhound - Norwegian Grey drawn from FDA CVM filings.

Data updated September 2026

The verdict

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Elkhound - Norwegian Grey ranks #237 of 510 by total reports (93) and #219 of 275 by death-coded share (3.2%). National dual: Retriever - Labrador is #1 of 510 by total adverse-event reports (93,675) at death-coded-share rank 195 of 275 breeds with at least 50 reports (3.7%); separately, Atlantic Salmon (Salmo salar) is #1 highest death-coded share at 99.0% (report rank #233).

93,675
Retriever - Labrador reports (#1)
99.0%
Atlantic Salmon (Salmo salar) death share (#1)
#237
This breed, reports of 510
#219
This breed, death share of 275

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Elkhound - Norwegian Grey has 93 reports now versus 88 in that prior snapshot: 5 more (5.7%).

Report change
+5
Death-coded reports
+0
Death-coded share
−0.2 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Elkhound - Norwegian Grey changes

Total Reports

93

Above-median volume

Deaths Reported

3

of 93 reports

Death-coded share of reports

3.2%

Lowest death-coded share

Avg Age at Report

5.6 yr

23.5 kg avg weight

Death-Coded Outcome Share

Elkhound - Norwegian Grey death-coded reports 3.2%
Cross-breed median

3.2% of 93 elkhound - norwegian grey reports involved a death outcome.

How to read this number

Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.

Where Elkhound - Norwegian Grey's death-coded share sits among indexed breeds

Death-coded share of FDA CVM reports, breeds with ≥50 reports (July 2026 extract)

3% 20th percentile Higher share than 20% of 275 indexed breeds

5%–10%: 1 indexed breeds (0%). This entry sits in this band. 20%–25%: 2 indexed breeds (1%). Above this entry. 25%–30%: 3 indexed breeds (1%). Above this entry. 30%–35%: 4 indexed breeds (1%). Above this entry. 35%–40%: 5 indexed breeds (2%). Above this entry. 40%–45%: 6 indexed breeds (2%). Above this entry. 45%–50%: 3 indexed breeds (1%). Above this entry. 50%–55%: 7 indexed breeds (3%). Above this entry. 55%–60%: 7 indexed breeds (3%). Above this entry. 60%–65%: 21 indexed breeds (8%). Above this entry. 65%–70%: 11 indexed breeds (4%). Above this entry. 70%–75%: 15 indexed breeds (5%). Above this entry. 75%–80%: 13 indexed breeds (5%). Above this entry. 80%–85%: 11 indexed breeds (4%). Above this entry. 85%–90%: 12 indexed breeds (4%). Above this entry. 90%–95%: 12 indexed breeds (4%). Above this entry. 95%–100%: 142 indexed breeds (52%). Above this entry. Elkhound - Norwegian Grey 5% 100% every breed with ≥50 FDA reports, bucketed by value

Each bar is a band; taller bars hold more indexed breeds. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source FDA Center for Veterinary Medicine, openFDA adverse event extract (PlainBreed) · July 2026 extract

This histogram uses the same ≥50-report cohort as the highest death-coded share ranking. A higher share means more of this breed's reported events were death-coded, not a mortality rate for living animals.

Average weight at time of report: 23.5 kg (51.8 lbs)

Top Reported Reactions

Vomiting 12
Lack of efficacy (endoparasite) - roundworm NOS 8
Lack of efficacy (bacteria) - Borrelia 8
Lack of efficacy (ectoparasite) - tick NOS 7
Seizure NOS 6

Most Referenced Drugs

Pyrantel Pamoate;Sarolaner 31
Moxidectin 13
Sarolaner 10
Bedinvetmab 10
Carprofen 5

Outcome Breakdown

Ongoing
57 (61.3%)
Outcome Unknown
18 (19.4%)
Recovered/Normal
15 (16.1%)
Euthanized
3 (3.2%)

Gender Distribution

Male 59 (63.4%)
Female 33 (35.5%)
Unknown 1 (1.1%)

Reports by Year

Year Reports Trend
2012 1
2013 3
2014 3
2016 2
2017 5
2018 6
2019 10
2020 3
2021 10
2022 3
2023 11
2024 16
2025 15
2026 5

Elkhound - Norwegian Grey: low death-coded share in the FDA CVM extract

Signature read: Elkhound - Norwegian Grey's 3.2% death-coded share is in the lower third of the ≥50-report cohort (median 4.8%). According to FDA CVM filings indexed on PlainBreed as of July 2026 extract, Elkhound - Norwegian Grey sits at #237 of 510 by report volume among all breeds and #171 of 298 among dog breeds, with 93 reports and 3 (3.2%) death-coded. On death-coded share among breeds with ≥50 reports, it ranks #219 of 275. Mean age at report: 5.6 years, average weight 23.5 kg (51.8 lbs).

Top reported signs: Vomiting (12), Lack of efficacy (endoparasite) - roundworm NOS (8), Lack of efficacy (bacteria) - Borrelia (8). Most-referenced drug: Pyrantel Pamoate;Sarolaner (31 reports), followed by Moxidectin (13) and Sarolaner (10).

Outcome coding on 93 status-recorded reports is dominated by Ongoing (61.3%). Annual submissions ranged 1-2,026 across 14 years on file.

Dog Breeds With a Similar Report Volume

Showing 6 of 297 dog breeds in our dataset, ranked by closest report volume.

Borzoi
91 reports · 5.5% death-coded
Terrier - Lakeland
90 reports · 1.1% death-coded
Chin
89 reports · 3.4% death-coded
Terrier - Fox Smooth
97 reports · 5.2% death-coded
Affenpinscher
88 reports · 5.7% death-coded
Poodle - Medium size
98 reports · 3.1% death-coded

Nationwide breeds with similar profiles

Two openFDA-derived peer sets for Elkhound - Norwegian Grey, both outside the Dog family so the neighborhoods are not species containment (the similar-volume list above stays within species).

Similar death-coded share

Nearest other-species breeds with ≥50 reports (3.2% death-coded here).

Oriental 3.1% · Cat Birman (Sacred Birman) 3.1% · Cat American Curl Shorthair 3.5% · Cat Oldenburg 2.8% · Horse

Similar average weight

Nearest other-species breeds by reported average weight (23.5 kg here).

Mixed (Sheep) 24.9 kg · Sheep Crossbred Caprine/goat 21.7 kg · Goat Pygmy 20.3 kg · Goat Fish (other) 32.4 kg · Fish

What to do with this dog

A report does not prove a drug caused the reaction, and popular breeds simply generate more reports.

Frequently Asked Questions

How many FDA adverse event reports involve Elkhound - Norwegian Grey? ▼
There are 93 adverse event reports involving Elkhound - Norwegian Grey in the FDA database, of which 3 were death-coded (3.2% of those reports). That is a share of REPORTED events, not a mortality rate for the breed: adverse events reach the FDA when something goes wrong, so the denominator is reports, never the population of animals. According to the same FDA CVM extract, Elkhound - Norwegian Grey ranks #237 of 510 by report volume among all breeds PlainBreed indexes (#171 of 298 among dog breeds).
Where does Elkhound - Norwegian Grey sit among other breeds in PlainBreed's corpus? ▼
According to FDA CVM report volume, Elkhound - Norwegian Grey is #237 of 510 breeds indexed on PlainBreed (same ordering as the most-reported-breeds ranking). Inside Dog, it is #171 of 298. Among breeds with at least 50 reports, its death-coded share ranks #219 of 275 (same cohort as highest-death-rate). These are placement ranks in the reporting corpus, not clinical risk scores.
What are the most common adverse reactions reported for Elkhound - Norwegian Grey? ▼
The most commonly reported adverse reactions for Elkhound - Norwegian Grey are Vomiting (12 reports), Lack of efficacy (endoparasite) - roundworm NOS (8 reports), Lack of efficacy (bacteria) - Borrelia (8 reports), Lack of efficacy (ectoparasite) - tick NOS (7 reports), Seizure NOS (6 reports).
What drugs are most frequently associated with Elkhound - Norwegian Grey adverse events? ▼
The drugs most frequently referenced in Elkhound - Norwegian Grey adverse event reports are Pyrantel Pamoate;Sarolaner (31 reports), Moxidectin (13 reports), Sarolaner (10 reports), Bedinvetmab (10 reports), Carprofen (5 reports).
What is the average age of Elkhound - Norwegian Grey in adverse event reports? ▼
The average age of Elkhound - Norwegian Grey at the time of adverse event reports is 5.6 years, with an average weight of 23.5 kg (51.8 lbs).

Compare a breed's report volume against how common the breed is before drawing conclusions. See our methodology for how the death-coded share and rankings are computed, or read breed-specific reporting patterns and FDA CVM reporting.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Elkhound - Norwegian Grey (Dog), extract as of July 2026 extract. 93 reports · 3 death-coded (3.2% of reports, not a mortality rate) · #237 of 510 by volume.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →